Target Delineation in Postoperative Radiotherapy for Head and Neck Cancer after Flap Reconstruction
This paper explains the controversy about including all of a large reconstruction flap in the RT target volume versus only the perimeter of the flap. Available guidelines regarding the issue are reviewed as are outcome studies that inform the subject.
Category
  • Head and Neck Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
The Role for Consolidative Local Therapy in Stage IV Non-Small Cell Lung Cancer for Oligometastases and Beyond: How are We Improving Outcomes for Patients?
Patients with Stage IV Lung cancer vary in their response to the numerous systemic therapies and are living longer. The role of aggressive local therapy or metastatic directed therapy (MDT) is critical for radiation oncologists and surgeons.
Category
  • Lung Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Pushing the Boundaries: Re-Irradiation for Pediatric Brain Tumors
Over the last 10 years, new studies have emerged demonstrating efficacy and safety of re-irradiation for children with recurrent brain tumors.
Category
  • Central Nervous System
  • Pediatric Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Lessons From HyTEC: Brain Necrosis, Optic Neuropathy and Brachial Plexopathy After Stereotactic Radiotherapy
HyTEC (Hypo-fractionated or “Hy”-dose per fraction, Treatment Effects in the Clinic) was an American Association of Physicists in Medicine-led initiative focusing on hypofractionated SBRT/SABR and stereotactic radiosurgery in adults.
Category
  • SBRT
  • Central Nervous System
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Science Highlights 2023: Breast Cancer
This session highlights the most clinically relevant abstracts within the Breast Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Breast Cancer
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 Certificate of Attendance
Science Highlights 2023: Genitourinary Cancer
This session highlights the most clinically relevant abstracts within the Genitourinary Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Genitourinary Cancer
Format
  • Science Highlights
  • CME only
Credits
  • 0.25 Certificate of Attendance
Science Highlights 2023: Gastrointestinal Cancer
This session highlights the most clinically relevant abstracts within the Gastrointestinal Cancer track of the 2023 ASTRO Annual Meeting scientific program.
Category
  • Gastrointestinal Cancer
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Science Highlights 2023: Head and Neck Cancer
This session highlights the most clinically relevant abstracts within the Head and Neck Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Head and Neck Cancer
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Innovative Radiation Therapy Approaches: Benefits & Challenges - Global Perspective
MRI-guided Radiation Therapy (MRgRT), FLASH proton therapy, concurrent immunotherapy, and radiation therapy and SBRT for oligometastatic disease, are emerging technologies and approaches to optimize cancer care.
Category
  • Immunotherapy
  • SBRT
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Radiobiology-guided Innovations in the Integration of Radiation & Immunotherapies
Radiation and immunotherapies are commonly utilized sequentially or concurrently for the treatment of cancer patients, yet we are still developing our understanding of the optimal approaches for safely and effectively integrating these treatments.
Category
  • Immunotherapy
  • SBRT
  • Radiobiology
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance

Pages